Michael Law, Assistant Professor, University of British Columbia, compares Canadian generic drug prices to those found in New Zealand and the United States to demonstrate the potential for additional savings in Canada. Law argues that replacing arbitrary price regulations with a system of generic tendering would lead to lower generic prices. Law addresses common criticisms of tendering, including the potential for drug shortages and pharmacy closures.
Pharmacare 2020 is an evidence- and experience- informed conversation on the future of drug coverage in Canada. This video was filmed during a Pharmacare 2020 symposium held in Vancouver, BC on February 26th and 27th, 2013.
This work is licensed under a Creative Commons Attribution 4.0 International License.